← Open Payments lookup

DAVID DAWES: Open Payments

NPI 1255383501 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$795 in 26 payments from 10 companies in 2025. Trend: 2023 $1,469 · 2024 $440 · 2025 $795

Food & beverage: $795
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$263
E.R. Squibb & Sons, L.L.C.3$140
Neurocrine BioSciences, Inc.1$94
ABBVIE INC.4$83
Janssen Pharmaceuticals, Inc4$73
Teva Pharmaceuticals USA, Inc.3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
Luye Pharma (USA) Ltd.1$23
Axsome Therapeutics, Inc.1$19
Alkermes, Inc.1$17

Products named: REXULTI, COBENFY, INGREZZA, VRAYLAR, INVEGA SUSTENNA, UZEDY, CAPLYTA, ERZOFRI EXTENDED-RELEASE.

Industry payments across LA — which companies pay providers there.